Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/20/2018.
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-464-17
- Dosage Form
- Injection
- Presentation
- Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)
- Initial Posting
- 02/20/2018
- Revised Date